Alvotech wins FDA approval to add US manufacturing capacity for Humira biosimilar SIMLANDI

Alvotech received FDA approval for added US manufacturing capacity for its Humira biosimilar SIMLANDI, doubling drug substance capacity at its Reykjavik site.

Detected & updated continuously · Source: Nebula

Story subjects

Alvotech Ordinary SharesFood and Drug AdministrationUnited States

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula